They're designed to provide essential nutrients while supporting your reduced calorie needs, helping to maintain muscle mass, and promoting satiety.
Nevertheless, patient reports indicate that some individuals do experience these sensations during treatment, warranting careful consideration of possible mechanisms
Semaglutide is considered off-label for the treatment of weight loss but its favourable effects have been documented in clinical studies: In a 26 week study with 703 adults, Oral Semaglutide contributed to 5% body weight reduction, which was significantly more substantial than the weight loss in the placebo group
Lancet Neurol 14(8):855866
Patient Assurance Program data
For instance, the South African Diabetes Advocacy has reported a significant increase in the prescription of GLP-1 receptor agonists, particularly for patients with type 2 diabetes and cardiovascular risks